Standard Care | Low Risk

BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE (Target Up and Up Pain Relieving Cleansing)

BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE risk profile, scheduling, and guidance for claims professionals and care workers . Also known as Target Up and Up Pain Relieving Cleansing.

Source: FDA Updated April 2026

BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE (brand names: Target Up and Up Pain Relieving Cleansing) is classified as Low risk (1 risk points) by AllMeds. It is a S3 medication under the TGA in Australia. FDA approved in the United States. Topical local anaesthetic combination with minimal systemic effects.

Key Takeaways

  • TGA Schedule: S3 in Australia
  • Risk level: Low (1 points)
  • Recommended maximum duration: 14 days

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S3 Not PBS listed
United States (FDA) Rx only FDA approved

Risk Profile

Risk Level Low
Risk Points 1
CNS Depressant No
Respiratory Risk No
Max Duration 14 days

Topical local anaesthetic combination with minimal systemic effects.

Regulatory and Compliance Guidance

When BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.

Australia TGA / PBS / State Schemes

Classified as S3 under the Therapeutic Goods Administration (TGA).

United States FDA / CDC / State WC

FDA approved for use in the United States.

Need to assess this medication across your caseload?

Run a full risk assessment including BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE interactions and compliance checks.

AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.